SWX:ROPPharmaceuticals
Roche Holding (SWX:ROP) Valuation Check As Obesity And Oncology Milestones Draw Attention
Roche Holding (SWX:ROP) is back in focus after a string of late May and early June product updates in obesity treatments and oncology, including fresh U.S. regulatory decisions and new clinical data presentations.
See our latest analysis for Roche Holding.
Despite the flurry of obesity and oncology updates, momentum in the shares has eased, with the 90 day share price return down 13.68% and the year to date share price return down 4.85%, even as the 1 year total shareholder return stands at...